Friday, January 20, 2006

H5N1 News: Roche Defends Tamiflu

Via Red Herring.

Swiss pharmaceutical maker Roche disputed an article published in the British medical journal The Lancet warning against an over-reliance on Tamiflu to treat avian and seasonal flu, and said Friday that animal tests showed Tamiflu could work against the H5N1 virus associated with avian flu.

Roche cited “rigorous clinical studies” showing a 38 percent reduction in the severity of symptoms of people using Tamiflu to treat seasonal flu, 67 percent reduction in secondary complications such as bronchitis, pneumonia, and sinusitis, and a 37 percent reduction in the duration of seasonal flu.

In an article published Thursday in The Lancet, researchers from the University of Queensland in Australia and Cochrane Vaccines Field in Rome said they found no “credible evidence” that Tamiflu could treat bird flu.

0 Comments:

Post a Comment

<< Home